The prevalence of amphenicol resistance in Escherichia coli isolated from pigs in mainland China from 2000 to 2018: A systematic review and meta-analysis

PLoS One. 2020 Feb 11;15(2):e0228388. doi: 10.1371/journal.pone.0228388. eCollection 2020.

Abstract

Background: Amphenicols have been widely used in the pig industry in China, leading to varying degrees of drug resistance.

Methods: The systematic review was performed according to PRISMA (Preferred Reported Items for Systematic Reviews and Meta-Analysis) recommendations on studies investigating the prevalence of amphenicol-resistant Escherichia coli (E. coli) isolated from pig in mainland China from 2000 to 2018, a random-effects model was selected, then followed by meta-analysis.

Results: A total of 103 articles were included in the study. The results of the meta-analysis revealed that the pooled summarized prevalence of resistance to chloramphenicol (CAP) was 72.31% (95% confidence interval (95% CI) = 67.12%-77.23%) and to florfenicol (FF) was 58.64% (95% CI = 52.48%-64.67%). During the past 18 years, the resistance rate to CAP remained high initially but then declined rapidly after 2012, whereas the resistance rate to FF plateaued (54.13%-59.60%) from 2000-2018. In different parts of China, the rate of resistance to amphenicols among E. coli isolates was fairly consistent, with the exception of the north and northwest regions.

Conclusions: In 2002, the veterinary use of CAP was prohibited and its resistance levels in E. coli isolated from pigs was initially maintained at a high level but then showed an obvious downward trend in recent years. Resistance to commonly used FF remained at a high but stable level.

Publication types

  • Meta-Analysis
  • Research Support, Non-U.S. Gov't
  • Systematic Review

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology
  • China / epidemiology
  • Chloramphenicol / pharmacology*
  • Drug Resistance, Bacterial*
  • Escherichia coli / drug effects
  • Escherichia coli / isolation & purification*
  • Escherichia coli Infections / drug therapy
  • Escherichia coli Infections / epidemiology
  • Escherichia coli Infections / microbiology
  • Escherichia coli Infections / veterinary*
  • Swine
  • Swine Diseases / drug therapy
  • Swine Diseases / epidemiology*
  • Swine Diseases / microbiology

Substances

  • Anti-Bacterial Agents
  • Chloramphenicol

Grants and funding

This work was supported by grants from the National Natural Science Foundation of China (NSFC, No. 31672530, U1704117 and 31302106). http://www.nsfc.gov.cn/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.